These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 16467642)

  • 1. Cardiovascular risk of systolic versus diastolic blood pressure in Western and non-Western countries.
    Nishizaka MK; Calhoun DA
    J Hypertens; 2006 Mar; 24(3):435-6. PubMed ID: 16467642
    [No Abstract]   [Full Text] [Related]  

  • 2. Attributing risk to hypertension: what does it mean?
    Jackson R
    Am J Hypertens; 2009 Mar; 22(3):237-8. PubMed ID: 19229205
    [No Abstract]   [Full Text] [Related]  

  • 3. Blood pressure and cardiovascular risk profiles of Africans who migrate to a Western country.
    Dominguez LJ; Galioto A; Pineo A; Ferlisi A; Vernuccio L; Belvedere M; Costanza G; Putignano E; Barbagallo M
    Ethn Dis; 2008; 18(4):512-8. PubMed ID: 19157258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between cheese consumption and cardiovascular risk factors among adults.
    Houston DK; Driver KE; Bush AJ; Kritchevsky SB
    J Hum Nutr Diet; 2008 Apr; 21(2):129-40. PubMed ID: 18339053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between the achieved blood pressure and the incidence of cardiovascular events in Japanese hypertensive patients with complications: a sub-analysis of the CASE-J trial.
    Ogihara T; Saruta T; Rakugi H; Fujimoto A; Ueshima K; Yasuno S; Oba K; Takeda K; Higaki J; Nakao K;
    Hypertens Res; 2009 Apr; 32(4):248-54. PubMed ID: 19347033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of kidney disease and blood pressure on the development of cardiovascular disease: an overview from the Japan Arteriosclerosis Longitudinal Study.
    Ninomiya T; Kiyohara Y; Tokuda Y; Doi Y; Arima H; Harada A; Ohashi Y; Ueshima H;
    Circulation; 2008 Dec; 118(25):2694-701. PubMed ID: 19106392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Global risk and objectives in cardiovascular diseases].
    Güleç S
    Turk Kardiyol Dern Ars; 2009 Mar; 37 Suppl 2():1-10. PubMed ID: 19404044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical effect of lifestyle modification on cardiovascular risk in prehypertensives: PREHIPER I study].
    Márquez-Celedonio FG; Téxon-Fernández O; Chávez-Negrete A; Hernández-López S; Marín-Rendón S; Berlín-Lascurain S
    Rev Esp Cardiol; 2009 Jan; 62(1):86-90. PubMed ID: 19150019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cardiovascular risk stratification. Systolic, diastolic or pulse pressure?].
    Pede S; Lombardo M
    Ital Heart J Suppl; 2001 Apr; 2(4):356-8. PubMed ID: 19397006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining the role of renin/angiotensin-targeted antihypertensive therapy in decreasing cardiovascular risk: evidence, guideline evolution, and questions to be resolved.
    Probstfield J
    J Fam Pract; 2009 Jun; 58(6 Suppl):S1-8. PubMed ID: 19508849
    [No Abstract]   [Full Text] [Related]  

  • 11. Abdominal obesity and the spectrum of global cardiometabolic risks in US adults.
    Ghandehari H; Le V; Kamal-Bahl S; Bassin SL; Wong ND
    Int J Obes (Lond); 2009 Feb; 33(2):239-48. PubMed ID: 19050677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on the body mass index and waist circumference of aged with clustering of other cardiovascular risk factors].
    Zhang FM; Xu HJ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2007 Jan; 41(1):33-7. PubMed ID: 17484208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends and cardiovascular mortality effects of state-level blood pressure and uncontrolled hypertension in the United States.
    Ezzati M; Oza S; Danaei G; Murray CJ
    Circulation; 2008 Feb; 117(7):905-14. PubMed ID: 18268146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between the metabolic syndrome and the development of hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study-2 (CRISPS2).
    Cheung BM; Wat NM; Man YB; Tam S; Cheng CH; Leung GM; Woo J; Janus ED; Lau CP; Lam TH; Lam KS
    Am J Hypertens; 2008 Jan; 21(1):17-22. PubMed ID: 18091739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caffeinated coffee consumption, cardiovascular disease, and heart valve disease in the elderly (from the Framingham Study).
    Greenberg JA; Chow G; Ziegelstein RC
    Am J Cardiol; 2008 Dec; 102(11):1502-8. PubMed ID: 19026304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of global cardiovascular risk with nutritional versus nutritional plus physical activity intervention in Colombian adults.
    Mendivil CO; Cortés E; Sierra ID; Ramírez A; Molano LM; Tovar LE; Vargas C; Granados N; Pérez CE
    Eur J Cardiovasc Prev Rehabil; 2006 Dec; 13(6):947-55. PubMed ID: 17143127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular disease in the dialysis population: prognostic significance of arterial disorders.
    Guérin AP; Pannier B; Marchais SJ; London GM
    Curr Opin Nephrol Hypertens; 2006 Mar; 15(2):105-10. PubMed ID: 16481874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic thresholds for ambulatory blood pressure monitoring based on 10-year cardiovascular risk.
    Kikuya M; Hansen TW; Thijs L; Björklund-Bodegård K; Kuznetsova T; Ohkubo T; Richart T; Torp-Pedersen C; Lind L; Ibsen H; Imai Y; Staessen JA;
    Circulation; 2007 Apr; 115(16):2145-52. PubMed ID: 17420350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics and cardiovascular risk of new cases of type 2 diabetes in Otago, New Zealand, 1998-2004.
    Coppell K; Williams S; Anderson K; Lamb C; Mann J
    Diabetes Res Clin Pract; 2008 Dec; 82(3):396-401. PubMed ID: 18990463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Workplace-based cardiovascular risk management by community pharmacists: impact on blood pressure, lipid levels, and weight.
    John EJ; Vavra T; Farris K; Currie J; Doucette W; Button-Neumann B; Osterhaus M; Kumbera P; Halterman T; Bullock T
    Pharmacotherapy; 2006 Oct; 26(10):1511-7. PubMed ID: 16999661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.